These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31476369)

  • 1. Necroptosis signaling in liver diseases: An update.
    Saeed WK; Jun DW; Jang K; Koh DH
    Pharmacol Res; 2019 Oct; 148():104439. PubMed ID: 31476369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
    Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
    J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
    Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in study on the final executor of necroptosis MLKL and its inhibitors.
    Liu X; Tu H; Peng J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):242-251. PubMed ID: 36999471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necroptosis: a crucial pathogenic mediator of human disease.
    Choi ME; Price DR; Ryter SW; Choi AMK
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Interacting Serine/Threonine-Protein Kinase 3 (RIPK3)-Mixed Lineage Kinase Domain-Like Protein (MLKL)-Mediated Necroptosis Contributes to Ischemia-Reperfusion Injury of Steatotic Livers.
    Ni HM; Chao X; Kaseff J; Deng F; Wang S; Shi YH; Li T; Ding WX; Jaeschke H
    Am J Pathol; 2019 Jul; 189(7):1363-1374. PubMed ID: 31026418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIPK3 signaling and its role in the pathogenesis of cancers.
    Liu S; Joshi K; Denning MF; Zhang J
    Cell Mol Life Sci; 2021 Dec; 78(23):7199-7217. PubMed ID: 34654937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.
    Chen J; Kos R; Garssen J; Redegeld F
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
    Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
    Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Receptor Interacting Protein Kinases in the Liver.
    Dara L
    Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of pro-necroptotic molecules blunts necroptosis during myogenesis.
    Kim TY; Kang JH; Lee SB; Kang TB; Lee KH
    Biochem Biophys Res Commun; 2021 Jun; 557():33-39. PubMed ID: 33862457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer.
    Lin P; Lin C; He R; Chen H; Teng Z; Yao H; Liu S; Hoffman RM; Ye J; Zhu G
    Cell Death Dis; 2023 Jan; 14(1):6. PubMed ID: 36604411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed necrosis and necroptosis signalling.
    Feoktistova M; Leverkus M
    FEBS J; 2015 Jan; 282(1):19-31. PubMed ID: 25327580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Regulation of RIPK1 and Necroptosis.
    Xu D; Zou C; Yuan J
    Annu Rev Genet; 2021 Nov; 55():235-263. PubMed ID: 34813352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop.
    Tanzer MC; Tripaydonis A; Webb AI; Young SN; Varghese LN; Hall C; Alexander WS; Hildebrand JM; Silke J; Murphy JM
    Biochem J; 2015 Oct; 471(2):255-65. PubMed ID: 26283547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necroptosis in development and diseases.
    Shan B; Pan H; Najafov A; Yuan J
    Genes Dev; 2018 Mar; 32(5-6):327-340. PubMed ID: 29593066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.